Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700029929

Trial Profile

Clinical Trials Insight: 700029929

Phase of Trial: Phase I

Latest Information Update: 03 Mar 2011

At a glance

  • Drugs Davunetide (Primary)
  • Indications Alzheimer's disease
  • Focus Pharmacokinetics
  • Sponsors Allon Therapeutics
  • Most Recent Events

    • 03 Mar 2011 Results presented at the American Society for Clinical Pharmacology and Therapeutics in March 2011, according to an Allon Therapeutic media release.
    • 12 Aug 2008 Status changed from recruiting to completed according to Allon Therapeutics media release.
    • 12 Aug 2008 Results reported in Allon Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top